In numerous studies, researchers commonly employ the ratio of CD31 and α-SMA positive cells as an indicator to evaluate angiogenesis in the wound bed of patients diagnosed with T2DM. The gene discussed is ACTA1; the disease is type 2 diabetes mellitus.